Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience.

European journal of cancer (Oxford, England : 1990)·2026
Same author

European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

The Lancet. Oncology·2026
Same author

Critical appraisal of patient-reported and clinician-reported outcome measures assessing functional outcomes in lower extremity bone sarcoma patients-a COSMIN-based systematic review.

Journal of patient-reported outcomes·2026
Same author

Metastatic Ewing Sarcoma, Patterns of Care and Outcomes of Patients in a Real-Life National Setting Over a Decade.

Cancer medicine·2026
Same author

Response to letter re: Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterations.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Clinical Presentation and Tumour Burden in Head and Neck Sarcomas: Implications for Early Diagnosis and Referral.

Cancers·2026

Related Experiment Video

Updated: Jun 25, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.4K

Emerging therapies in Ewing sarcoma.

Sandra J Strauss1, Pablo Berlanga2, Martin G McCabe3

  • 1Department of Oncology, University College London Cancer Institute, London, United Kingdom.

Current Opinion in Oncology
|May 22, 2024
PubMed
Summary
This summary is machine-generated.

New therapies targeting Ewing sarcoma biology show promise for improving outcomes in adolescents and young adults. Research focuses on novel agents and immunotherapies to overcome treatment resistance in this rare cancer.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.6K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K

Related Experiment Videos

Last Updated: Jun 25, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.4K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.6K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K

Area of Science:

  • Pediatric Oncology
  • Sarcoma Research
  • Cancer Therapeutics

Background:

  • Ewing sarcoma is an aggressive cancer primarily affecting adolescents and young adults.
  • Current treatments involving chemotherapy and local therapy have limited efficacy for metastatic or recurrent disease.
  • There is a critical need for improved therapeutic strategies to enhance patient outcomes.

Purpose of the Study:

  • To review emerging therapeutic targets and strategies for Ewing sarcoma.
  • To highlight advancements in understanding Ewing sarcoma biology.
  • To discuss the potential of novel agents and immunotherapies in clinical trials.

Main Methods:

  • Review of recent scientific literature and clinical trial data.
  • Analysis of novel therapeutic targets and their mechanisms of action.
  • Evaluation of immunotherapeutic approaches, including CAR-T-cell therapy.

Main Results:

  • Improved understanding of Ewing sarcoma biology has identified novel therapeutic targets.
  • Tyrosine kinase inhibitors, EWSR1::FLI1-targeting agents, and DNA damage/cell cycle/apoptotic pathway modulators show promise.
  • Immunotherapies, such as GD2-directed CAR-T-cell therapy, are emerging as potential treatments.
  • Collaborative clinical trials are establishing international standards of care and enabling adaptive study designs.

Conclusions:

  • International collaboration between clinicians and biologists is crucial for advancing Ewing sarcoma treatment.
  • Prioritizing promising therapies and developing biomarkers will accelerate clinical translation.
  • Emerging therapies offer new hope for improving outcomes in Ewing sarcoma patients.